ABSTRACT
Similarly to severe acute respiratory syndrome (SARS) and Middle East respiratory syndrome (MERS), [1] coronavirus disease 2019 (COVID-19) is associated with a significant burden of cardiovascular (CV) complications ranging from isolated myocardial injury (elevation of cardiac troponin [cTn]) to acute heart failure, cardiac arrhythmias, venous and pulmonary thromboembolism, arterial thrombotic events, acute coronary syndromes, myocarditis, cardiogenic shock, and cardiac arrest [2, 3]. © The Editor(s) (if applicable) and The Author(s), under exclusive license to Springer Nature Switzerland AG 2022.
ABSTRACT
In COVID-19 patients, CV manifestations include venous and pulmonary thromboembolism, acute heart failure, cardiac arrhythmias, arterial thrombotic events, acute coronary syndromes, myocarditis, cardiogenic shock, and cardiac arrest. © The Editor(s) (if applicable) and The Author(s), under exclusive license to Springer Nature Switzerland AG 2022.